The European Patent Office, EPO, has issued a decision to grant European patent for exidavnemab, a drug candidate being developed as a treatment for synucleinopathies such as Parkinson’s disease and Multiple System Atrophy (MSA).

The post BioArctic receives European patent for exidavnemab appeared first on NLS.

Euro-BioImaging Finland, the research infrastructure of Finnish bioimaging, has received funding of about EUR 28 million from the Research Council of Finland.

The post Record funding for Finnish bioimaging appeared first on NLS.

A DKK  200 million grant from the Novo Nordisk Foundation will enable a new national “one point of entry” gateway to health data to be established in Denmark.

The post New Danish national gateway to health data appeared first on NLS.

The Unites States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for a patent application with claims covering a method of treating rheumatoid arthritis (RA) with resomelagon (AP1189) in combination with methotrexate (MTX).

The post SynAct Pharma receives Notice of Allowance for grant of US patent appeared first on NLS.

Zelluna has developed, scaled and automated its manufacturing process for its TCR-NK cell therapies.

The post Zelluna reaches milestone – Manufacturing process established appeared first on NLS.

RWK Bidco AB, a newly formed company indirectly wholly owned by KKR Funds, has announced a recommended public tender offer to the shareholders of Biotage to transfer all of the ordinary shares of Biotage to RWK BidCo for SEK 145 in cash per ordinary share.

The post KKR makes SEK 11.6 billion bid for Biotage appeared first on NLS.

Oncopeptides has announced the publication of new real-world data (RWD) that further support the effectiveness and tolerability of melflufen, branded in Europe as Pepaxti, in patients with relapsed, refractory multiple myeloma (RRMM).

The post Oncopeptides announces new RWD data appeared first on NLS.

“To be able to control costs and serve patients, the world will need biosimilars,” says Róbert Wessman, Icelandic businessman and entrepreneur.

The post Global health & Local efforts: Opening up the market of biosimilars appeared first on NLS.

The new institute, AI Science Institute, brings together researchers, industry and technology developers to further strengthen knowledge development and practical application of artificial intelligence.

The post Boston Consulting Group launches AI research institute appeared first on NLS.

Ahead of the EU Commission's presentation of a new strategy for life sciences, four industry organizations in Sweden, Lif – the research-based pharmaceutical companies, SwedenBIO, IKEM, and Swedish Medtech, have submitted a joint statement.

The post Joint Swedish response to the EU’s new life science strategy appeared first on NLS.